Adjuvant radiation therapy improves patient survival in early‐stage merkel cell carcinoma: A 15‐year single‐institution study

Objectives/Hypothesis Merkel cell carcinoma (MCC) is a rare and aggressive neuroendocrine neoplasm of the skin. Growing evidence supports the benefit of postoperative adjuvant radiation therapy (RT) for locoregional control, but whether it improves overall survival (OS) has been debated. Our objecti...

Ausführliche Beschreibung